PubMed

Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial.

Read TR, Carey D, Mallon P, Mijch A, Goodall R, Hudson F, Wand H, Emery S.

AIDS. 2009 Oct 23;23(16):2222-3.PMID: 19773634 [PubMed - in process]Related articles

Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.

Byakwaga H, Murray JM, Petoumenos K, Kelleher AD, Law MG, Boyd MA, Emery S, Mallon PW, Cooper DA.

AIDS Res Hum Retroviruses. 2009 Jun;25(6):756-76.PMID: 19500017 [PubMed - indexed for MEDLINE]Related articles

Is PPARgamma a Prospective Player in HIV-1-Associated Bone Disease?

Cotter EJ, Mallon PW, Doran PP.

PPAR Res. 2009;2009:421376. Epub 2009 Mar 23.PMID: 19325916 [PubMed - in process]Related articlesFree article

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.

Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M.

AIDS Res Hum Retroviruses. 2009 Apr;25(4):457-61.PMID: 19320601 [PubMed - indexed for MEDLINE]Related articles

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.

Mallon PW, Sedwell R, Rogers G, Nolan D, Unemori P, Hoy J, Samaras K, Kelleher A, Emery S, Cooper DA, Carr A; Rosey Investigators.

J Infect Dis. 2008 Dec 15;198(12):1794-803.PMID: 18954260 [PubMed - indexed for MEDLINE]Related articles

Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.

Gallagher DP, Kieran J, Sheehan G, Lambert J, Mahon N, Mallon PW.

Clin Infect Dis. 2008 Aug 1;47(3):e36-8.PMID: 18558878 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral therapy-induced lipid alterations: in-vitro, animal and human studies.

Mallon PW.

Curr Opin HIV AIDS. 2007 Jul;2(4):282-92.PMID: 19372900 [PubMed - in process]Related articles

The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.

Winston A, Mallon PW, Satchell C, MacRae K, Williams KM, Schutz M, Law M, Cooper DA, Emery S.

Clin Infect Dis. 2007 Jun 1;44(11):1475-83. Epub 2007 Apr 18.PMID: 17479946 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy.

Mallon PW.

AIDS Rev. 2007 Jan-Mar;9(1):3-15. Review.PMID: 17474309 [PubMed - indexed for MEDLINE]Related articles

The clinical pharmacology of antiretrovirals in development.

Winston A, Mallon PW, Boffito M.

Expert Opin Drug Metab Toxicol. 2006 Jun;2(3):447-58. Review.PMID: 16863445 [PubMed - indexed for MEDLINE]Related articles

Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.

Mallon PW, Miller J, Kovacic JC, Kent-Hughes J, Norris R, Samaras K, Feneley MP, Cooper DA, Carr A.

AIDS. 2006 Apr 24;20(7):1003-10.PMID: 16603852 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral therapy and dyslipidaemia: unlocking the code.

Mallon PW.

PLoS Med. 2006 Mar;3(3):e85. Epub 2006 Jan 24. Review. No abstract available. PMID: 16420104 [PubMed - indexed for MEDLINE]Related articlesFree article

Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy.

Mallon PW, Sedwell R, Unemori P, Kelleher A, Cooper DA, Carr A.

Antivir Ther. 2005;10 Suppl 2:M101-8. Review.PMID: 16152711 [PubMed - indexed for MEDLINE]Related articles

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

Winston A, Bloch M, Carr A, Amin J, Mallon PW, Ray J, Marriott D, Cooper DA, Emery S.

J Antimicrob Chemother. 2005 Aug;56(2):380-7. Epub 2005 Jul 4.PMID: 15996972 [PubMed - indexed for MEDLINE]Related articlesFree article

In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA, Carr A; SAMA Investigators.

J Infect Dis. 2005 May 15;191(10):1686-96. Epub 2005 Apr 12.PMID: 15838796 [PubMed - indexed for MEDLINE]Related articles

Therapeutic approaches to combating lipoatrophy: do they work?

Martin A, Mallon PW.

J Antimicrob Chemother. 2005 May;55(5):612-5. Epub 2005 Mar 10. Review.PMID: 15761072 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.

Kovacic JC, Martin A, Carey D, Wand H, Mallon PW, Feneley MP, Emery S, Cooper DA, Carr A; ROSEY Investigators.

Antivir Ther. 2005;10(1):135-43.PMID: 15751771 [PubMed - indexed for MEDLINE]Related articles

Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.

Mallon PW, Wand H, Law M, Miller J, Cooper DA, Carr A; HIV Lipodystrophy Case Definition Study; Australian Lipodystrophy Prevalence Survey Investigators.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):156-62.PMID: 15671800 [PubMed - indexed for MEDLINE]Related articles

11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 8-11 February 2004: where are the breakthroughs?

Mallon PW.

J HIV Ther. 2004 Feb;9(1):19-22. No abstract available. PMID: 15587480 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy.

Mallon PW, Miller J, Cooper DA, Carr A.

AIDS. 2003 May 2;17(7):971-9.PMID: 12700446 [PubMed - indexed for MEDLINE]Related articles